共 103 条
[1]
Smith A(2015)Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the Uk’s Haematological Malignancy Research Network Br J Cancer 112 1575-84
[2]
Crouch S(2012)British Committee for Standards in Haematology. Guidelines for the investigation and management of mantle cell lymphoma Br J Haematol 159 405-26
[3]
Lax S(2012)Mantle cell lymphoma Crit Rev Oncol Hematol 82 78-101
[4]
Li J(2012)Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches Cancer Control 19 227-35
[5]
Painter D(2014)Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii83-92
[6]
Howell D(2015)Mantle cell lymphoma: evolving management strategies Blood 125 48-55
[7]
McKay P(2013)ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma Ann Oncol 24 857-77
[8]
Leach M(2013)Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network Leuk Lymphoma 54 699-707
[9]
Jackson R(2008)A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Blood 111 558-65
[10]
Cook G(2012)Treatment of older patients with mantle-cell lymphoma N Engl J Med 367 520-31